SEATTLE, Oct. 23, 2012 – The U.S. Food and Drug Administration (FDA) is investigating a multistate outbreak of fungal meningitis and joint infections. It appears the outbreak is due to the contamination of an injectable steroid medication called methylprednisolone acetate produced by the New England Compounding Center (NECC). Swedish has never carried the methylprednisolone acetate product produced by NECC.
For more information about the investigation of products from NECC, consumers can call the FDA’s Division of Drug Information at 855-543-DRUG (3784) and press * to get the most recent updates regarding the mulitistate meningitis outbreak, report an adverse event, or speak directly to a pharmacist. Additional information is also available on the FDA web site and the Centers for Disease Control and Prevention web site.